Kayla R Tunehag
Overview
Explore the profile of Kayla R Tunehag including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
2
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tunehag K, Pearce A, Fox L, Stouffer G, Solander S, Lee C
Clin Transl Sci
. 2025 Jan;
18(1):e70131.
PMID: 39822142
In neurovascular settings, including treatment and prevention of ischemic stroke and prevention of thromboembolic complications after percutaneous neurointerventional procedures, dual antiplatelet therapy with a P2Y12 inhibitor and aspirin is the...
2.
Fox L, Tunehag K, Nguyen A, Reed S, Shastri D, Quig N, et al.
Pharmacogenomics
. 2024 Oct;
25(12-13):503-513.
PMID: 39360670
To evaluate the feasibility and impact of using genotype to guide selection of antiplatelet therapy in patients undergoing intracranial aneurysm treatment with a flow diversion stent in a real-world clinical...
3.
Tunehag K, Thomas C, Franchi F, Rossi J, Keeley E, Anderson R, et al.
J Am Heart Assoc
. 2024 Jun;
13(12):e033791.
PMID: 38874073
Background: Cytochrome P450 2C19 (CYP2C19) intermediate and poor metabolizer patients exhibit diminished clopidogrel clinical effectiveness after percutaneous coronary intervention (PCI). However, outcome studies to date have lacked racial diversity. Thus,...
4.
Tunehag K, George B, Samuels S, Vo K, Arya V, Abulwerdi G, et al.
J Clin Pharmacol
. 2024 Jan;
64(6):697-703.
PMID: 38294346
Food effect (FE) studies characterize food-drug interactions that may alter the efficacy or safety of a drug, but these studies are not conducted in pediatric patients. Pediatric patients have substantial...